RT Book, Section
A1 Gallegos, Robert P.
A1 Gudbjartsson, Tomas
A1 Aranki, Sary
A2 Cohn, Lawrence H.
SR Print(0)
ID 55922238
T1 Chapter 42. Mitral Valve Replacement
T2 Cardiac Surgery in the Adult, 4e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-163310-9
LK accesssurgery.mhmedical.com/content.aspx?aid=55922238
RD 2024/04/20
AB This  chapter  discusses  the  surgical  indications,  operative  techniques,  and  early  and  late  follow-up  after  implantation  of  mechanical  and  bioprosthetic  mitral  valve  devices.  The  valves  that  are  discussed  are  those  that  are  currently  (2010)  approved  by  the  FDA.  Figure  42-1  shows  the  current  FDA-approved  prosthetic  mitral  valve  devices,  including  the  Starr-Edwards  ball-and-cage  valve  (historical  relevance  only),  the  Omnicarbon  tilting-disk  valve,  the  Medtronic  Hall  tilting-disk  valve,  the  St.  Jude  Medical  bileaflet  valve,  the  Carbomedics  bileaflet  valve,  the  ATS  bileaflet  valve,  and  the  On-X  bileaflet  valve.  The  FDA-approved  bioprosthetic  valve  devices  are  shown  in  Fig.  42-2  and  include  the  Hancock  II  porcine  valve,  the  Carpentier-Edwards  porcine  valve,  the  Carpentier-Edwards  pericardial  valve,  the  Mosaic  porcine  valve,  and  the  Biocor  porcine  valve.